iRadimed (IRMD)
(Delayed Data from NSDQ)
$44.40 USD
-1.75 (-3.79%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $44.26 -0.14 (-0.32%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth B Momentum C VGM
Balance Sheet
Fiscal Year End for iRadimed Corporation falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 50 | 58 | 63 | 52 | 46 |
Receivables | 12 | 13 | 5 | 5 | 7 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 13 | 5 | 4 | 4 | 4 |
Other Current Assets | 1 | 1 | 4 | 3 | 2 |
Total Current Assets | 76 | 77 | 76 | 64 | 59 |
Net Property & Equipment | 9 | 2 | 2 | 2 | 2 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 2 | 1 | 1 | 1 | 2 |
Intangibles | 3 | 2 | 1 | 1 | 1 |
Deposits & Other Assets | 0 | 1 | 0 | 0 | 0 |
Total Assets | 92 | 86 | 83 | 71 | 67 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 2 | 2 | 1 | 1 | 1 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 3 | 3 | 3 | 2 | 3 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 11 | 3 | 3 | 2 | 2 |
Total Current Liabilities | 16 | 9 | 7 | 5 | 6 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 3 | 1 | 2 | 2 | 3 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 21 | 12 | 11 | 10 | 11 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 28 | 26 | 25 | 24 | 19 |
Retained Earnings | 43 | 47 | 47 | 38 | 36 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 71 | 74 | 72 | 61 | 56 |
Total Liabilities & Shareholder's Equity | 92 | 86 | 83 | 71 | 67 |
Total Common Equity | 71 | 74 | 72 | 61 | 56 |
Shares Outstanding | 12.60 | 12.50 | 12.30 | 12.20 | 11.40 |
Book Value Per Share | 5.67 | 5.89 | 5.87 | 5.03 | 4.87 |
Fiscal Year End for iRadimed Corporation falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 45 | 50 | 47 | 46 |
Receivables | NA | 13 | 12 | 13 | 11 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 13 | 13 | 12 | 8 |
Other Current Assets | NA | 1 | 1 | 1 | 1 |
Total Current Assets | NA | 72 | 76 | 72 | 66 |
Net Property & Equipment | NA | 9 | 9 | 9 | 9 |
Investments & Advances | NA | 0 | 0 | 0 | 0 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 2 | 2 | 2 | 2 |
Intangibles | NA | 3 | 3 | 2 | 2 |
Deposits & Other Assets | NA | 0 | 0 | 0 | 0 |
Total Assets | NA | 88 | 92 | 87 | 81 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 1 | 2 | 3 | 3 |
Current Portion Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 3 | 3 | 2 | 3 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 3 | 11 | 2 | 2 |
Total Current Liabilities | NA | 8 | 16 | 8 | 8 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 3 | 3 | 3 | 3 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 0 | 0 | 0 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 12 | 21 | 13 | 12 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 0 | 0 | 0 | 0 |
Capital Surplus | NA | 29 | 28 | 28 | 27 |
Retained Earnings | NA | 47 | 43 | 47 | 42 |
Other Equity | NA | 0 | 0 | 0 | 0 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 76 | 71 | 75 | 69 |
Total Liabilities & Shareholder's Equity | NA | 88 | 92 | 87 | 81 |
Total Common Equity | 0 | 76 | 71 | 75 | 69 |
Shares Outstanding | 12.60 | 12.60 | 12.60 | 12.60 | 12.60 |
Book Value Per Share | 0.00 | 6.04 | 5.67 | 5.92 | 5.48 |